Back to Trades
Albers Jeffrey W.
DirectorCIK 0001638474
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 3
- Active
- 2025–2026
Albers Jeffrey W., Director, accounts for 6 disclosed filings worth $46.1M, spread across 3 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $3.1M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Aug 10 | SYRE Spyre Therapeutics, Inc. | Albers Jeffrey W. | Director | Sell | $2.4M |
| Jun 25 | KYMR Kymera Therapeutics, Inc. | Albers Jeffrey W. | Insider | Award | $606.0K |
| May 29 | SYRE Spyre Therapeutics, Inc. | Albers Jeffrey W. | Director | Award | $582.0K |
| Dec 8 | KYMR Kymera Therapeutics, Inc. | Albers Jeffrey W. | Insider | Sell | $448.8K |
| Oct 14 | KYMR Kymera Therapeutics, Inc. | Albers Jeffrey W. | Insider | Sell | $295.9K |
| Jul 21 | BPMC Blueprint Medicines Corp | Albers Jeffrey W. | Director | Disposed | $41.4M |
6 filings